Sodium valproate (NON childbearing potential) - Epilepsy
You are here : Home > Formulary Search > Sodium valproate (NON childbearing potential) - Epilepsy
Status 1
- Crushable tablets
- Gastro-resistant tablets
- Modified release tablets
- Oral solution
- Tablets
Status 2
- Capsules (slow release)
- Granules (slow release)
Documentation
PAD Profile
Other Indications
Below are listed other indications that Sodium valproate (NON childbearing potential) is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Epilepsy.
- Brivaracetam
- Cannabis (medicinal)
- Carbamazepine
- Cenobamate
- Clobazam
- Clonazepam
- Eslicarbazepine acetate
- Ethosuximide
- Gabapentin
- Lacosamide
- Lamotrigine
- Levetiracetam
- Oxcarbazepine
- Perampanel
- Phenobarbital
- Phenytoin
- Pregabalin
- Primidone
- Rufinamide
- Sodium valproate (with childbearing potential)
- Stiripentol
- Sulthiame
- Tiagabine
- Topiramate
- Vigabatrin
- Zonisamide
Committee Recommendations (2)
Three infographics have been produced to clarify in which situations review by two specialists may be required for patients who are prescribed valproate:
• for female patients under 55 years old
• for male patients under 55 years old
• for male and female patients 55 years and older
The Surrey Heartlands APC reviewed the Blue traffic light status for patients with epilepsy and WITHOUT child-bearing potential.
The Blue status remains with the expectation that treatment will be initiated and stabilised by a specialist and patients will receive a minimum of 1 month supply from the specialist before transfer of care.
No supplementary information sheet is required